Tag: StockMarket

Be in the know. 12 key reads for Monday…

  1. Why Small-Cap Stocks Are Poised to Outpace Large-Caps (Barron’s)
  2. The tech giants are at risk of a 2001-style valuation collapse, says colorful SocGen strategist (MarketWatch)
  3. The Government Is Coming for Google and Other Big Tech Companies. What to Do With the Stocks. (Barron’s)
  4. Groundwork for US lawsuit vs. Google goes back to 2012 (New York Post)
  5. Oh, No, Zeta! The Energy Report 10/26/2020 (Phil Flynn)
  6. UPDATE 2-Ant Group to raise up to $34.4 bln in world’s biggest public offering (Reuters)
  7. Pfizer test experimental vaccine on 12-year-olds (CNN)
  8. Academics Say Momentum Factor Is ‘Much Weaker’ Than You Think (Institutional Investor)
  9. AstraZeneca COVID-19 Vaccine Data Shows Promising Signs In Older Age Group: FT (Benzinga)
  10. ‘Don’t believe anything,’ says Nicole Kidman of twisty HBO thriller ‘The Undoing’ with Hugh Grant (USA Today)
  11. A Global Rebound Could Be Determined by How Freely Households Spend (Wall Street Journal)
  12. Cenovus and Husky to Merge in $2.89 Billion Deal (Wall Street Journal)

Be in the know. 12 key reads for Sunday…

  1. Card Companies, Surprised by Low Write-Offs, Seek New Customers (Bloomberg)
  2. Josh Younger on Rate Derivatives and Volatility (Podcast) (Bloomberg)
  3. The 2021 Ford Bronco and Bronco Sport Configurators Are Here, So Show Us Your Dream Rigs (The Drive)
  4. Elon Musk’s 2 Rules For Learning Anything Faster (entrepreneurshandbook)
  5. Vegas Strip’s live performances to resume (Fox Business)
  6. Larry David Reveals All-Time Favorite ‘Seinfeld’ Episode (Hollywood Reporter)
  7. Natural Gas Looks to Join the Energy Merger Wave. EQT Is Said to Be Pursuing CNX. (Barron’s)
  8. Ready for another Big Tech hearing/earnings doubleheader? (MarketWatch)
  9. Stock-market investors brace for busiest week of earnings in October’s final hurrah (MarketWatch)
  10. Starboard tries to find another winner in the fintech space (CNBC)
  11. Look Past Election Blues for Health Stocks (Wall Street Journal)
  12. AstraZeneca and Johnson & Johnson COVID-19 Vaccine Trials to Resume in the United States (TrialSiteNews)

Be in the know. 25 key reads for Saturday…

  1. Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers (Barron’s)
  2. How Coke Is Shaking Things Up — and Why Its Stock Is a Buy (Barron’s)
  3. Stocks will see a big surge in the 1st quarter of 2021 after stimulus passes, forecasts billionaire investor Paul Tudor Jones (Business Insider)
  4. “Tech Workers Are Never Going Back to the Office”: The Pandemic Housing-Market Explosion Could Upend Silicon Valley as We Know It (Vanity Fair)
  5. U.S. natural gas exports to Mexico have increased in the first nine months of 2020 (eia)
  6. Matthew McConaughey on His Success Playbooks, the Powerful Philosophy of Greenlights, and Choosing the Paths Less Traveled (#474) (Tim Ferriss)
  7. 3 Undervalued Travel Stocks We Like (Morningstar)
  8. Psychology, Behavior & Markets (Investor Amnesia)
  9. Rotation (theirrelevantinvestor)
  10. Reflections on 100 Baggers (woodlockhousefamilycapital)
  11. What Sharks Can Teach Us About Survivorship Bias (Farnam Street)
  12. Who Says Value’s Dead? (thefelderreport)
  13. Value: If Not Now, When? (pzena)
  14. Berkshire Announced $19 billion in Investments After Buffett Blasted for Not Buying (validea)
  15. Emerging Market Stocks Are Breaking Out. These Companies Can Rival U.S. Tech Giants (Barron’s)
  16. Epidemiologists Stray From the Covid Herd (Wall Street Journal)
  17. BofA Securities Stays Bullish on 4 Former Blue-Chip Stocks Trading Under $10 (24/7 Wall Street)
  18. Halloween Trading Strategy: S&P 500 Up 85% of the Time (Almanac Trader)
  19. The USA vs. Google (Financial Times)
  20. Smaller Hedge Funds Are Outpacing Their Larger Rivals (Forbes)
  21. Ray Dalio on the Decline of Real Interest Rates (Podcast) (Bloomberg)
  22. De Tomaso Is Moving to the US So It Can Build the New P72 Supercar Stateside (Robb Report)
  23. Rebecca Takes Place in the Ultimate English Estate (Architectural Digest)
  24. These Classic Alfa Romeo Concepts Could Sell for $20 Million (Maxim)
  25. First Drive: The New McLaren GT (Maxim)

Be in the know. 15 key reads for Friday…

  1. F.D.A. Approves Gilead’s Remdesivir as First Drug to Treat Covid-19 (New York Times)
  2. Wells Fargo Is Said to Discuss Sale of Its Asset-Management Arm (Bloomberg)
  3. Pelosi-Mnuchin Talks Drag, Likely Pushing Stimulus Past Election (Bloomberg)
  4. Intel Beat Earnings Expectations. Why Its Stock Is Tumbling. (Barron’s)
  5. Trump Seizes On Biden Oil Comment to Warn Swing State Voters (Bloomberg)
  6. China Economic Rebound Pushes Copper Prices to Multiyear High (Wall Street Journal)
  7. UK retail sales rise at record pace in 3rd quarter, as Brits splash out on clothes, shoes and dining out (Business Insider)
  8. Warren Buffett’s great-nephew joins the SPAC boom by listing a $150 million blank-check company (Business Insider)
  9. GE stock price target raised to $9.00 from $8.50 at UBS (MarketWatch)
  10. Why Goldman Sachs sees a 2021 bull market brewing for commodities (MarketWatch)
  11. These are the stocks to short when a COVID vaccine is ready, says JPMorgan (MarketWatch)
  12. Oil Production Cuts Could Be Extended: Putin (ZeroHedge)
  13. Does Intel Deserve More Credit For Q3 Earnings? (24/7 Wall Street)
  14. Copper’s ‘unignorable’ strength is saying bullish things about the economy (MarketWatch)
  15. European equities rise on upbeat earnings (Financial Times)